Literature DB >> 23321789

Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity.

Brandon S Pruett1, Michael F Salvatore.   

Abstract

Delivery of exogenous glial cell line-derived neurotrophic factor (GDNF) increases locomotor activity in rodent models of aging and Parkinson's disease in conjunction with increased dopamine (DA) tissue content in substantia nigra (SN). Striatal GDNF infusion also increases expression of GDNF's cognate receptor, GFRα1, and tyrosine hydroxylase (TH) ser31 phosphorylation in the SN of aged rats long after elevated GDNF is no longer detectable. In aging, expression of soluble GFRα1 in the SN decreases in association with decreased TH expression, TH ser31 phosphorylation, DA tissue content, and locomotor activity. Thus, we hypothesized that, in aged rats, replenishing soluble GFRα1 in SN could reverse these deficits and increase locomotor activity. We determined that the quantity of soluble GFRα1 in young adult rat SN is ~3.6 ng. To replenish age-related loss, which is ~30 %, we infused 1 ng soluble GFRα1 bilaterally into SN of aged male rats and observed increased locomotor activity compared to vehicle-infused rats up to 4 days following infusion, with maximal effects on day 3. Five days after infusion, however, neither locomotor activity nor nigrostriatal neurochemical measures were significantly different between groups. In a separate cohort of male rats, nigral, but not striatal, DA, TH, and TH ser31 phosphorylation were increased 3 days following unilateral infusion of 1 ng soluble GFRα1into SN. Therefore, in aged male rats, the transient increase in locomotor activity induced by replenishing age-related loss of soluble GFRα1is temporally matched with increased nigral dopaminergic function. Thus, expression of soluble GFRα1 in SN may be a key component in locomotor activity regulation through its influence over TH regulation and DA biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23321789      PMCID: PMC4037235          DOI: 10.1007/s12035-013-8397-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  59 in total

1.  Extrapyramidal signs in cognitively intact elderly people.

Authors:  R Prettyman
Journal:  Age Ageing       Date:  1998-09       Impact factor: 10.668

2.  Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys.

Authors:  Richard Grondin; Wayne A Cass; Zhiming Zhang; John A Stanford; Don M Gash; Greg A Gerhardt
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

3.  Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.

Authors:  Steven S Gill; Nikunj K Patel; Gary R Hotton; Karen O'Sullivan; Renée McCarter; Martin Bunnage; David J Brooks; Clive N Svendsen; Peter Heywood
Journal:  Nat Med       Date:  2003-03-31       Impact factor: 53.440

4.  Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys.

Authors:  Richard Grondin; Zhiming Zhang; Ai Yi; Wayne A Cass; Navin Maswood; Anders H Andersen; Dennis D Elsberry; Michael C Klein; Greg A Gerhardt; Don M Gash
Journal:  Brain       Date:  2002-10       Impact factor: 13.501

5.  Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod.

Authors:  Filip Bergquist; Haydeh Niazi Shahabi; Hans Nissbrandt
Journal:  Brain Res       Date:  2003-05-23       Impact factor: 3.252

6.  Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.

Authors:  Michael F Salvatore; Jin-Lu Zhang; Delia M Large; Patsy E Wilson; Clelland R Gash; Theresa Currier Thomas; John W Haycock; Guoying Bing; John A Stanford; Don M Gash; Greg A Gerhardt
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

7.  Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system.

Authors:  Biljana Georgievska; Deniz Kirik; Anders Björklund
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

8.  Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum.

Authors:  John W Haycock; Laurence Becker; Lee Ang; Yoshiaki Furukawa; Oleh Hornykiewicz; Stephen J Kish
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

9.  Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys.

Authors:  Navin Maswood; Richard Grondin; Zhiming Zhang; John A Stanford; Stewart P Surgener; Don M Gash; Greg A Gerhardt
Journal:  Neurobiol Aging       Date:  2002 Sep-Oct       Impact factor: 4.673

Review 10.  Novel functions and signalling pathways for GDNF.

Authors:  Hannu Sariola; Mart Saarma
Journal:  J Cell Sci       Date:  2003-10-01       Impact factor: 5.285

View more
  18 in total

1.  Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.

Authors:  Tanya Chotibut; Samantha Meadows; Ella A Kasanga; Tamara McInnis; Mark A Cantu; Christopher Bishop; Michael F Salvatore
Journal:  Mov Disord       Date:  2017-06-20       Impact factor: 10.338

2.  Dissociation of Striatal Dopamine and Tyrosine Hydroxylase Expression from Aging-Related Motor Decline: Evidence from Calorie Restriction Intervention.

Authors:  Michael F Salvatore; Jennifer Terrebonne; Mark A Cantu; Tamara R McInnis; Katy Venable; Parker Kelley; Ella A Kasanga; Brian Latimer; Catherine L Owens; Brandon S Pruett; Yongmei Yu; Robert Luedtke; Michael J Forster; Nathalie Sumien; Donald K Ingram
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-12-12       Impact factor: 6.053

3.  Effect of Gingerol on Cisplatin-Induced Pica Analogous to Emesis Via Modulating Expressions of Dopamine 2 Receptor, Dopamine Transporter and Tyrosine Hydroxylase in the Vomiting Model of Rats.

Authors:  Weibin Qian; Xinrui Cai; Yingying Wang; Xinying Zhang; Hongmin Zhao; Qiuhai Qian; Zhihong Yang; Zhantao Liu; Junichi Hasegawa
Journal:  Yonago Acta Med       Date:  2016-06-29       Impact factor: 1.641

4.  ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.

Authors:  Michael F Salvatore
Journal:  J Neurochem       Date:  2014-01-27       Impact factor: 5.372

5.  Differential effects of amphetamine and GBR-12909 on orolingual motor function in young vs aged F344/BN rats.

Authors:  Susan Smittkamp; Heather Spalding; Hongyu Zhang; John A Stanford
Journal:  Psychopharmacology (Berl)       Date:  2014-06-13       Impact factor: 4.530

6.  Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency.

Authors:  Michael F Salvatore; Tamara R McInnis; Mark A Cantu; Deana M Apple; Brandon S Pruett
Journal:  Mol Neurobiol       Date:  2018-07-28       Impact factor: 5.590

7.  Initiation of calorie restriction in middle-aged male rats attenuates aging-related motoric decline and bradykinesia without increased striatal dopamine.

Authors:  Michael F Salvatore; Jennifer Terrebonne; Victoria Fields; Danielle Nodurft; Cori Runfalo; Brian Latimer; Donald K Ingram
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

8.  Exercise-Mediated Increase in Nigral Tyrosine Hydroxylase Is Accompanied by Increased Nigral GFR-α1 and EAAC1 Expression in Aging Rats.

Authors:  Jennifer C Arnold; Michael F Salvatore
Journal:  ACS Chem Neurosci       Date:  2015-12-08       Impact factor: 4.418

9.  Getting to compliance in forced exercise in rodents: a critical standard to evaluate exercise impact in aging-related disorders and disease.

Authors:  Jennifer C Arnold; Michael F Salvatore
Journal:  J Vis Exp       Date:  2014-08-22       Impact factor: 1.355

10.  Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.

Authors:  Michael F Salvatore; Erin S Calipari; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2016-05-10       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.